Skip to main content

Table 2 Summary of methods: anaesthesia, MRI sequences, imaging parameters and contrast media for two cats with FHN

From: Feline hippocampal and piriform lobe necrosis as a consequence of severe cluster seizures in two cats in Finland

  Case 1 Case 2
Anaesthesia for MRI Medetomidinea 75 µg/kg IM, propofolb IV isofluranec, O2 Medetomidinea 30 µg/kg IM, propofolb IV isofluranec, O2
MRI equipment and positioning 0.2 T Vet-MR, Esaote S.p.A, Genoa, Italy) with the cat placed in sternal recumbency in a human knee coil 0.2 T Vet-MR, Esaote S.p.A, Genoa, Italy) with the cat placed in sternal recumbency in a human knee coil
MRI sequences and imaging parameters and contrast media 1st examination Pre-and post-contrast T1W trans (TR 460 ms, TE 18 ms, acquisition matrix 256 × 192, FOV 150 × 150 mm, slice thickness 4.5 mm, interslice gap 0.4 mm) Pre-and post-contrast T1W trans (TR 750 ms, TE 26 ms, matrix 256 × 192, FOV 140 × 140 mm, slice thickness 3.5 mm, interslice gap 0.3 mm)
T2W trans and sag (TR 2,600 ms, TE 90 ms, acquisition matrix 192 × 192, FOV 130 × 130 mm, slice thickness 4.5 mm, interslice gap 0.4 mm) T2W trans and sag (TR 3,000 ms, TE 90 ms, acquisition matrix 256 × 192, FOV 170 × 170 mm, slice thickness 3.5 mm, interslice gap 0.3 mm)
Gadopentetd 0.1 mmol/kg IV Gadopentetd 0.1 mmol/kg IV
MRI sequences and imaging parameters and contrast media 2nd examination Pre-contrast T1W trans (TR 750 ms, TE 26 ms, acquisition matrix 256 × 192, FOV 170 × 170 mm, slice thickness 4.0 mm, interslice gap 0.4 mm) Pre- and post-contrast T1W trans (TR 800 ms, TE 26 ms, acquisition matrix 256 × 192, FOV 170 × 170 mm, slice thickness 4.0 mm, interslice gap 0.4 mm)
Post-contrast T1W trans (TR 750 ms, TE 26 ms, acquisition matrix 256 × 192, FOV 170 × 170 mm, slice thickness 4.0 mm, interslice gap 0.4 mm) dors (TR 600 ms, TE 26 ms, acquisition matrix 256 × 192, FOV 180 × 180 mm, slice thickness 4.0 mm, interslice gap 0.4 mm)
T2W trans and sag (TR 3,000 ms, TE 80 ms, acquisition matrix 256 × 192, FOV 180 × 180 mm, slice thickness 4.0 mm, interslice gap 0.4 mm) T2W trans (TR 3,000 ms, TE 80 ms, acquisition matrix 192 × 192, FOV 180 × 180 mm, slice thickness 4.0 mm, interslice gap 0.4 mm) and sag (TR 3,000 ms, TE 90 ms, acquisition matrix 192 × 192, FOV 170 × 170 mm, slice thickness 4.0 mm, interslice gap 0.4 mm)
FLAIR trans and dors (TR 5,100 ms, TE 80 ms, acquisition matrix 288 × 192, FOV 220 × 220 mm, slice thickness 4.0 mm, interslice gap 0.4 mm) FLAIR dors (TR 2,000 ms, TE 80 ms, acquisition matrix 256 × 192, FOV 200 × 200 mm, slice thickness 4.0 mm, interslice gap 0.4 mm)
Gadopentetd 0.1 mmol/kg IV Gadopentetd 0.1 mmol/kg IV
  1. MRI magnetic resonance, Trans transverse, Dors dorsal, Sag sagittal, FOV field of view, TR repetition time, TE echo time, IV intravenously, IM intramuscularly.
  2. aDomitor vet, Orion Pharma Animal Health, Finland.
  3. bRapinovet® vet, ScheringPlough Animal Health, Denmark.
  4. cIsoFlo®vet, Orion Pharma Animal Health, Abbot Laboratories Ltd, Great Britain; Isofluran Baxter, Baxter, Sweden.
  5. dMagnevist®, Bayer Schering Pharma, Finland.